Clinical Trials
53 trialsTTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Zhujiang Hospital
To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
Fudan University
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
Peking Union Medical College Hospital
MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
Emory University
The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma
Fudan University
Irinotecan and Temozolomide for Ewing Sarcoma
Peking University People's Hospital
ERASE-TMZ
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
Sun Yat-sen University
TEMOTRAD01
Assistance Publique - Hôpitaux de Paris
A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma
First Affiliated Hospital of Zhejiang University
Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
Peking Union Medical College Hospital
A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Shandong Cancer Hospital and Institute
AEO
MetVital, Inc.
Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma
Peking University Cancer Hospital & Institute
RACTAC
Regina Elena Cancer Institute
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
People's Hospital of Guangxi Zhuang Autonomous Region
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
The Second Hospital of Hebei Medical University
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Guangzhou Medical University
A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
Huashan Hospital
Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor
Peking University
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor
ChineseAMS
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor
ChineseAMS
Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
China Medical University, China
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
McGill University Health Centre/Research Institute of the McGill University Health Centre
Radiation Therapy and Combination Chemotherapy for Medulloblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases
Sun Yat-sen University
Temozolomide as Maintenance Therapy in Small Cell Lung Cancer
Chinese PLA General Hospital
Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
Zhejiang Cancer Hospital
A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases
Far Eastern Memorial Hospital
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
National Cancer Institute (NCI)
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
National Cancer Institute (NCI)
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
National Cancer Institute (NCI)
Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）
Shandong Cancer Hospital and Institute
Temozolomide in Treating Women With Advanced Breast Cancer
National Cancer Institute (NCI)
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
National Cancer Institute (NCI)
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
National Cancer Institute (NCI)
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
National Cancer Institute (NCI)
Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
Shandong Cancer Hospital and Institute
Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas
Peking Union Medical College Hospital
CNSLymphoma
Assistance Publique - Hôpitaux de Paris
ExCentric
Northern Sydney and Central Coast Area Health Service
PATSGO
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
SentoClone AB
KARE003
Kentuckiana Cancer Institute
KARE004
Kentuckiana Cancer Institute
Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
National Cancer Institute (NCI)